Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1779229rdf:typepubmed:Citationlld:pubmed
pubmed-article:1779229lifeskim:mentionsumls-concept:C0443286lld:lifeskim
pubmed-article:1779229lifeskim:mentionsumls-concept:C0439855lld:lifeskim
pubmed-article:1779229lifeskim:mentionsumls-concept:C0163995lld:lifeskim
pubmed-article:1779229pubmed:issue4lld:pubmed
pubmed-article:1779229pubmed:dateCreated1992-3-11lld:pubmed
pubmed-article:1779229pubmed:abstractTextThe reaction of the antitumor octahedral complex trans-RuCl2(DMSO)4 with 2'deoxyguanosine leads to the reversible formation of two diastereoisomeric monoadducts and one biadduct. This shows that it is possible to accommodate two purine bases in a cis configuration in an octahedral transition metal complex which exhibits antiblastic activity. All the product compounds are characterized by a guanine moiety coordination via the N7 atom. A marked decrease (about two pK units) is observed for the N1H pKa of the coordinated guanine moieties. The reversibility of the monodentate binding could explain the low toxicity of the ruthenium(II) complexes.lld:pubmed
pubmed-article:1779229pubmed:languageenglld:pubmed
pubmed-article:1779229pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1779229pubmed:citationSubsetIMlld:pubmed
pubmed-article:1779229pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1779229pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1779229pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1779229pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1779229pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1779229pubmed:statusMEDLINElld:pubmed
pubmed-article:1779229pubmed:monthSeplld:pubmed
pubmed-article:1779229pubmed:issn0162-0134lld:pubmed
pubmed-article:1779229pubmed:authorpubmed-author:ViglinoPPlld:pubmed
pubmed-article:1779229pubmed:authorpubmed-author:EspositoGGlld:pubmed
pubmed-article:1779229pubmed:authorpubmed-author:QuadrifoglioF...lld:pubmed
pubmed-article:1779229pubmed:authorpubmed-author:CauciSSlld:pubmed
pubmed-article:1779229pubmed:issnTypePrintlld:pubmed
pubmed-article:1779229pubmed:volume43lld:pubmed
pubmed-article:1779229pubmed:ownerNLMlld:pubmed
pubmed-article:1779229pubmed:authorsCompleteYlld:pubmed
pubmed-article:1779229pubmed:pagination739-51lld:pubmed
pubmed-article:1779229pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1779229pubmed:meshHeadingpubmed-meshheading:1779229-...lld:pubmed
pubmed-article:1779229pubmed:meshHeadingpubmed-meshheading:1779229-...lld:pubmed
pubmed-article:1779229pubmed:meshHeadingpubmed-meshheading:1779229-...lld:pubmed
pubmed-article:1779229pubmed:meshHeadingpubmed-meshheading:1779229-...lld:pubmed
pubmed-article:1779229pubmed:meshHeadingpubmed-meshheading:1779229-...lld:pubmed
pubmed-article:1779229pubmed:meshHeadingpubmed-meshheading:1779229-...lld:pubmed
pubmed-article:1779229pubmed:meshHeadingpubmed-meshheading:1779229-...lld:pubmed
pubmed-article:1779229pubmed:meshHeadingpubmed-meshheading:1779229-...lld:pubmed
pubmed-article:1779229pubmed:meshHeadingpubmed-meshheading:1779229-...lld:pubmed
pubmed-article:1779229pubmed:year1991lld:pubmed
pubmed-article:1779229pubmed:articleTitleReaction of the octahedral antitumor complex trans-RuCl2 (DMSO)4 with 2'deoxyguanosine.lld:pubmed
pubmed-article:1779229pubmed:affiliationInstitute of Biology, School of Medicine, University of Udine, Italy.lld:pubmed
pubmed-article:1779229pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1779229pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed